An interventional study of Trans-radial and Trans-femoral in Exposure to Ionizing Radiation, Coronary Heart Disease and Vascular Access Complication, sponsored by Instituto de Cardiologia do Rio Grande do Sul. Completed at 1 site in Brazil. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2014-09-17.
Sponsored by Instituto de Cardiologia do Rio Grande do Sul · Not applicable, Interventional, and Treatment
Transradial approach (TRA) reduces vascular complications and access related-bleeding compared to transfemoral approach (TFA). However, this technique has been related to higher radiation exposure during coronary angiography and percutaneous coronary intervention. Previous studies have shown that TRA demands a long learning curve, and procedure success rate increases with operator's experience. Our hypothesis is that the higher radiation exposure during TRA is not a technique issue, but due to operator's expertise.
The aim of this study is to evaluate whether experienced operators with either TRA or TFA can perform diagnostic coronary angiography with similar radiation exposure.
3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.
This study's planned enrollment of 300 is above the median of 100 across 1,778 interventional studies indexed under Heart Diseases.
Browse Heart Diseases studies →Instituto de Cardiologia do Rio Grande do Sul is the lead sponsor of 74 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Coronary angiography performed through trans-radial access
Other: Trans-radial
Coronary angiography performed through trans-femoral access
Other: Trans-femoral
Coronary angiography performed through trans-radial access
Coronary angiography performed through trans-femoral access
Patient radiation exposure (mGy)
Patient radiation exposure (mGy)
Time frame: during coronary angiography
Physician radiation exposure (in uSv)
Physician radiation exposure (in uSv)
Time frame: during coronary angiography
Major adverse cardiac events
Major adverse cardiac events (death, stroke and vascular complications)
Time frame: 30 days
This study is completed, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto de Cardiologia do Rio Grande do Sul